Tacrolimus monotherapy in immunologically low-risk kidney transplant recipients: a pilot randomized-controlled study.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Sep 2017 Planned number of patients changed from 100 to 120.
- 30 Jul 2014 New trial record